Quit Smoking And Your Children Are Less Likely To Smoke
If both parents of a child never smoked, research shows that a child's odds of daily smoking are reduced by more than 70 percent compared to when both parents continue to smoke. And if both parents were smokers but quit, those same odds are reduced by nearly 40 percent. Additional research shows that mothers who quit are less likely to have children who start smoking.
As global leaders in tobacco control commemorate World No Tobacco Day (WNTD) on May 31st, the rallying cry is to prevent young people from starting to smoke. While the 2008 theme, "Tobacco-Free Youth" calls for additional limitations on the marketing practices of cigarette marketers and other comprehensive changes, a major determining factor of children's tobacco use is the smoking status of their parents.
"By quitting smoking, parents can play a major role in helping to end the vicious cycle of passing addiction from generation to generation," said Howard Marsh, M.D., medical director, GlaxoSmithKline Consumer Healthcare. "Parents who want to take this important step on May 31st should get help from proven smoking cessation treatments such as therapeutic nicotine to increase their chances of staying off cigarettes for good."
Smoking remains one of the leading causes of preventable death and disease and one of the most powerful and important addictions to break. That said, many smokers can't do it alone. Evidence-based treatments such as therapeutic nicotine including (US: NicoDerm CQ, Nicorette and Commit) (ex-US) NiQuitin and Nicabate in combination with counseling offers a significantly better chance of quitting versus cold turkey.
Consider these statistics:
-- Therapeutic nicotine smoking cessation aids, Nicorette gum (United States only), NicoDerm CQ patch and Commit lozenge, and NiQuitin and Nicabate brands outside of the United States, have helped over 6.5 million people around the world quit smoking and, as a result, have significantly reduced their exposure to the risks of cancer and other smoking-related diseases.
-- More than one billion patches, lozenges and gums were sold in 2007 to help smokers quit.
-- Quitters using therapeutic nicotine can double their chances of success versus quitting without help.
-- More than 110 studies involving approximately 40,000 smokers have demonstrated the safety of therapeutic nicotine, even in populations with specific health conditions, such as diabetes, high blood pressure, lung disease, and existing heart disease.
-- International and national guidelines from the United States, United Kingdom and the World Health Organization (WHO) recommend therapeutic nicotine as a first-line treatment for smoking addiction.
-- Committed Quitters is the only free, tailored Web-based behavioral support program that has been proven to increase a smoker's chances of quitting. This program is available as Click2Quit in the UK.
-- More than 13 billion packs of cigarettes have gone un-sold as a result of smokers quitting with therapeutic nicotine.
GlaxoSmithKline's line of therapeutic nicotine products such as Nicorette gum (United States only), NicoDerm CQ patch and Commit lozenge, and NiQuitin and Nicabate brands outside of the United States, are easy to access in thousands of retail outlets and pharmacies worldwide. These products are designed specifically to break the daily addiction cycle by offering a gradual, controlled delivery of nicotine to the body, helping to relieve cravings and withdrawal symptoms.